By admin.bio No comments yet
Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.
Biofortuna supports World Cancer Day
4th February 2021
Biofortuna shortlisted for 2020 Bionow awards.
20th January 2021
Biofortuna sets a new production record.
10th December 2020